Evaluation of Abnormal Liver Chemistries
Official guideline of the American College of Gastroenterology.
Initial Assessment for both Acute and Chronic Abnormalities
Initial Assessment for both Acute and Chronic Abnormalities
Confirm abnormal LFTs (repeat labs and/or do confirmatory test).
If acute abnormalities repeat test negative, no further work-up. Otherwise:
Hepatic
Hepatitis A and E – If acute hepatitis, test for acute HAV infection with HAV IgM. If HAV, HBV, HCV negative, and exposure to HEV endemic area, test for acute HEV infection with HEV IgM.
Hepatitis B – Screen chronic HBV with HBsAg. Test acute HBV with HBsAg and anti-HBc IgM. Test high risk groups (endemic areas, MSM, drug use, dialysis, HIV, pregnant women, close contacts of HBV-infected patients).
Hepatitis C – Screen baby boomers & high risk populations (drug use, tattoos, piercings, transfusions, and high risk sexual conduct) with anti-HCV. Confirm with HCV-RNA.
AIH – If positive AST and ALT, test ANA, ASMA, & globulin level.
If chronic abnormalities repeated and still present, still test for common diseases:
Common
NAFLD – If ⇧ ALT and metabolic syndrome, DM, HLD, HTN, overweight or obese, then liver ultrasound.
ALD – If AST>ALT and drinking >140g/week (W) or >210g/week (M), counsel alcohol cessation.
Rare
AIH – If ⇧ AST and ALT, then test ANA, ASMA, and globulin level.
DILI – For ⇧ liver chemistries, obtain history of non-prescribed medications, complementary medicines, dietary or herbal supplements.
Wilson’s – If ⇧ AST and ALT and age < 55, then screen for low serum ceruloplasmin. Confirm with 24-hour urinary copper and slit-lamp eye exam.
PBC – If ALP high, regardless of bilirubin, test for AMA.
What do the icons mean?
How strong is the ACG's recommendation?
Strong recommendation
Intervention's desirable effects clearly outweigh undesirable effects.Very low quality evidence
Any estimate of effect is very uncertain.Literature